传汇控及马来亚银行保险分支入围竞投AXA新加坡业务
据《彭博通讯社》报道,汇控(00005.HK)及马来亚银行持有的保险分支Etiqa将角逐竞投AXA安盛於新加坡的业务,交易作价或达7亿美元。报道指两者在提交标书後已进入下一轮,据悉有另一家中资机构获邀出价。
安盛有意出售新加坡业务,而公司在2018年收购XL後已开始审视全球规模较细的业务,包括中东等的经营,以支付收购XL的交易。据悉其新加坡业务主要提供寿险及财产险,2019年收入达6.15亿欧元,另外亦有储蓄及投资服务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.